monalizumab,durvalumab,oleclumab
innate,medimmune,astrazeneca
['monali', 'neocoast', 'oleclumab', 'durva']
#esmo22 neocoast neoadj durva + oleclumab (anti cd73), monalizumab (anti nkg2a) or danva (anti-stat3): - modestly higher rates of mpr w combo s - change in nk &amp; cd8 tcell populatns w combos - kras, stk11, ret, alk seen in pts w/out mpr next step- ph ii neocoast2 
Thoracic Oncologist focused on immunotherapy for lung cancer & immune toxicity at Beaumont RCSI Cancer Centre Dublin; Adjunct Professor Johns Hopkins University